These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3261197)

  • 21. Limbic brain structures are important sites of kappa-opioid receptor-mediated actions in the rat: a [14C]-2-deoxyglucose study.
    Ableitner A; Herz A
    Brain Res; 1989 Jan; 478(2):326-36. PubMed ID: 2538203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local cerebral metabolic effects induced by nigral stimulation following ventromedial thalamic lesions. I: Basal ganglia and related motor structures.
    Savaki HE; Girault JA; Desban M; Glowinski J; Besson MJ
    Brain Res Bull; 1984 Jun; 12(6):609-16. PubMed ID: 6383525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats.
    Porrino LJ; Domer FR; Crane AM; Sokoloff L
    Neuropsychopharmacology; 1988 May; 1(2):109-18. PubMed ID: 3251493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the GABA receptor agonist, progabide, upon local cerebral glucose utilization.
    Cudennec A; Duverger D; Lloyd KG; MacKenzie ET; McCulloch J; Motohashi N; Nishikawa T; Scatton B
    Brain Res; 1987 Oct; 423(1-2):162-72. PubMed ID: 2823984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcortical changes in the regional uptake of [3H]-2-deoxyglucose in the brain of the monkey during experimental choreiform dyskinesia elicited by injection of a gamma-aminobutyric acid antagonist into the subthalamic nucleus.
    Mitchell IJ; Sambrook MA; Crossman AR
    Brain; 1985 Jun; 108 ( Pt 2)():405-22. PubMed ID: 4005529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
    Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ; Groover O; Smith Y
    Neurobiol Dis; 2017 Apr; 100():9-18. PubMed ID: 28042095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.
    Hartvig P; Lindquist NG; Aquilonius SM; d'Argy R; Bergström K; Bondesson U; Eckernäs SA; Gullberg P; Larsson BS; Lindberg B
    Life Sci; 1986 Jan; 38(1):89-97. PubMed ID: 3484535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rolling mouse Nagoya as a mutant animal model of basal ganglia dysfunction: determination of absolute rates of local cerebral glucose utilization.
    Yamaguchi T; Kato M; Fukui M; Akazawa K
    Brain Res; 1992 Dec; 598(1-2):38-44. PubMed ID: 1486501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of FG 7142 upon local cerebral glucose utilization suggest overlap between limbic structures important in anxiety and convulsions.
    Pratt JA; Laurie DJ; McCulloch J
    Brain Res; 1988 Dec; 475(2):218-31. PubMed ID: 3214732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
    Langston JW; Langston EB; Irwin I
    Acta Neurol Scand Suppl; 1984; 100():49-54. PubMed ID: 6333134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
    Calon F; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Exp Neurol; 2000 May; 163(1):191-9. PubMed ID: 10785458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.
    Kozlowski MR; Marshall JF
    Brain Res; 1980 Sep; 197(1):167-83. PubMed ID: 7397550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The distribution of alterations in energy metabolism in the rat brain produced by apomorphine.
    McCulloch J; Savaki HE; McCulloch MC; Jehle J; Sokoloff L
    Brain Res; 1982 Jul; 243(1):67-80. PubMed ID: 7116159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic aspects of aging brain and related disorders.
    Battistin L; Rigo A; Bracco F; Dam M; Pizzolato G
    Gerontology; 1987; 33(3-4):253-8. PubMed ID: 3498665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.